DexCom (DXCM) Misses Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
DexCom (DXCM) Reports Revenue In-Line with Pre-Release; Piper Jaffray Reiterates Overweight
November 5, 2015 9:53 AM ESTPiper Jaffray reiterated an Overweight rating on DexCom (NASDAQ: DXCM), and raised the price target to $107.00 (from $103.00), following the company's 3Q15 earnings report. DXCM reported revenue of $105.2M, in-line with its pre-release on October 15. 3Q results do not include $800K of revenue deferrals to 4Q related to... More
